| Product Information |
|
| Registration Number |
DR-XY45733
|
| Generic Name |
Empagliflozin + Linagliptin
|
| Brand Name |
Glyxambi
|
| Dosage Strength |
25mg/5mg
|
| Dosage Form |
Film-coated Tablet
|
| Classification |
Prescription Drug (RX)
|
| Pharmacologic Category |
-
|
| Packaging |
Alu-PVC/PVDC blister
|
| Manufacturer |
Boehringer Ingelheim Pharma GmbH & Co. KG
|
| Country of Origin |
Germany
|
| Trader |
|
| Importer |
Boehringer Ingelheim (Philippines), Inc.
|
| Distributor |
Boehringer Ingelheim (Philippines), Inc.
|
| Application Type |
-
|
| Issuance Date |
11 April 2022
|
| Expiry Date |
09 January 2027
|